ストックスクリーナーアプリを入手
336.39
2.03%
6.68
アフターアワーズ：
336.39
前日終値:
$329.71
開ける：
$328.45
24時間の取引高:
771.64K
Relative Volume:
0.91
時価総額：
$23.77B
収益：
$3.22B
当期純損益:
$542.70M
株価収益率:
44.97
EPS:
7.4805
ネットキャッシュフロー:
$458.00M
1週間 パフォーマンス:
+2.07%
1か月 パフォーマンス:
+6.31%
6か月 パフォーマンス:
+21.23%
1年 パフォーマンス:
+55.23%
1日の値動き範囲:
$327.61
$336.50
1週間の範囲:
$321.94
$336.50
52週間の値動き範囲:
$206.80
$336.82
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
336.39 | 23.17B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
403.18 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
143.92 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.12 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.30 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.26 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
Revvity Launches Signals AI to Advance Scientific R&D Workflows - TradingView
West Pharmaceutical opens the week with clear analyst consensus, shares hold near recent highs - AD HOC NEWS
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
The NovaPure Plunger from West Pharmaceuticaltight particle specs for sensitive biologics - AD HOC NEWS
West Pharmaceutical StockSunday background on valuation and growth drivers - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative - Yahoo Finance
Why West Pharmaceutical’s NovaGuard SA Pro quietly matters for everyday injections - AD HOC NEWS
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services Inc (WST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
West Pharmaceutical stock slips to weekly low amid conflicting momentum signals - Traders Union
Why West Pharmaceutical’s NovaPure plungers quietly matter for injectable drugs - AD HOC NEWS
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
West Pharmaceutical Services Inc (WST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
West Pharmaceutical Services Inc (WST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
West Pharmaceutical Services Inc (WST) Institutional Confidence - TradingKey
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Aluminum Crimp Vial Seals Market Forecast to 2035: Growth Accelerates on Biologic Drug Surge and RTU Adoption - IndexBox
Reasons to Retain Baxter International Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 - Macau Business
West pharmaceutical services strengthens support for china’s biologics ecosystem with integrated prefillable syringe system launch at CPHI China 2026 - The Sun Malaysia
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 #WestPharmaceuticalServices - Media OutReach Newswire
New release highlights: Westar Select Ready Pack vials target small-batch biologics - AD HOC NEWS
New price band, same precision: West’s Stelmi Ready Pack seeks broader biologics use - AD HOC NEWS
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum - Yahoo Finance
Is West Pharmaceutical Stock Outperforming the S&P 500? - Yahoo Finance
West Pharmaceutical Stock (US9523901012): Quiet trading day keeps valuation in focus - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Valuation Check After Recent Momentum And Premium P/E Ratio - Sahm
West Pharmaceutical Services (WST) Is an Injectable-Drug Infrastructure Story, Not Just a Packaging Supplier - AlphaStreet
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Stock (US9553061055): Valuation Metrics Under the Microscope on a Quiet Friday - AD HOC NEWS
West Pharmaceutical Stock (US9523901012): Valuation Metrics Under the Microscope - AD HOC NEWS
West Pharma’s GLP-1 Tailwinds Come With A Cybersecurity Footnote - Finimize
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards - Devdiscourse
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - TradingView
West Pharmaceutical Names Thermo Fisher Executive as CEO - MyChesCo
AMN Expands Language Services Portfolio With Jaide Health Deal - TradingView
Motley Fool Wealth Management LLC Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma raised to overweight at Barclays on fundamentals - MSN
West Pharmaceutical Services stock hits 52-week high at 331.43 USD - Investing.com Nigeria
West Pharmaceutical Services Inc (WST) Shares Surge 4.7% -- What GF Score of 96 Tells Investors - GuruFocus
Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 - Moomoo
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
1.49%
大文字化:
|
ボリューム (24 時間):